台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP01-4: Management of adverse events in patients with metastatic renal cell carcinoma receiving second-line targeted therapy: Real-world experience in Taiwan_鍾孝仁

2021-03-25 • 觀看: 6 • 回應: 0 • pdf
MP01-3: Docetaxel rechallenge improves survival in patients with metastatic castration-resistant prostate cancer: A retrospective study_吳芃諺

2021-03-25 • 觀看: 12 • 回應: 0 • pdf
MP01-2: Inherited variants of adiponectin and its receptors are associated with the time to castration-resistant prostate cancer_張哲維

2021-03-25 • 觀看: 12 • 回應: 0 • pdf
MP01-1: Immunotherapy with checkpoint inhibitors improves survival in patients with metastatic urothelial carcinoma_吳芃諺

2021-03-25 • 觀看: 16 • 回應: 0 • pdf
MP01-9: Geriatric nutritional risk index as a prognostic marker for patients with metastatic castration resistant prostate cancer receiving docetaxel_謝享宸

2021-03-25 • 觀看: 9 • 回應: 0 • pdf
10_Overview of Adrenal Testicular Cancer & Penile Cancer_吳振宇

2021-03-24 • 觀看: 29 • 回應: 0 • 影片
09_Overview of Renal Cell Carcinoma_康智雄

2021-03-24 • 觀看: 40 • 回應: 0 • 影片
08_Overview of Urothelial Carcinoma_李威明

2021-03-24 • 觀看: 25 • 回應: 0 • 影片
07_Overview of Prostate Cancer_蔡育賢

2021-03-24 • 觀看: 55 • 回應: 0 • 影片
05_Male LUTS and BPH_鄭元佐

2021-03-24 • 觀看: 23 • 回應: 0 • 影片
04_Urodynamic Study_吳俊賢

2021-03-24 • 觀看: 39 • 回應: 0 • 影片
03_Neurourology and Pharmacology_李偉嘉

2021-03-24 • 觀看: 24 • 回應: 0 • 影片

Prev
510
511
512
513
514
515
516
517
518
519
Next
/ 1052